Heart Failure
About
-
Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.
Load moreHeart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.
The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.
Load Less
Editor's choice
-
Haipeng Tang, Shaojie Tang, Weihua Zhou, et alArrhythmia & Electrophysiology Review 2017;6(2):69–74.
-
Ferdinando Iellamo, Karl Werdan, Krzysztof Narkiewicz, et alCardiac Failure Review 2017;3(1):40–5.
-
John J Atherton, Annabel HickeyCardiac Failure Review 2017;3(1):25–32.
Videos
-
14 May 2018 -
08 May 2018 -
08 May 2018 -
24 April 2018 -
24 April 2018 -
17 April 2018
Pages
-
Thomas A Zelniker, Eugene BraunwaldCardiac Failure Review 2019;5(1):27–30.DOI: https://doi.org/10.15420/cfr.2018.44.1
-
Tonje Thorvaldsen, Lars H LundCardiac Failure Review 2019;5(1):24–6.DOI: https://doi.org/10.15420/cfr.2018.35.1
-
Sajad Shehab, Christopher S HaywardCardiac Failure Review 2019;5(1):19–23.DOI: https://doi.org/10.15420/cfr.2018.23.2
-
Maria Rosa CostanzoCardiac Failure Review 2019;5(1):9–18.DOI: https://doi.org/10.15420/cfr.2018.29.2
